EMA advances 3Rs in regulatory testing
The agency’s 3Rs Working Party published its biennial report for 2023–2024, highlighting progress in promoting alternatives to animal testing while safeguarding scientific quality and animal welfare.
EMA supports New Approach Methodologies (NAMs) such as in vitro systems and computer modelling, develops scientific guidelines, provides early dialogue via the Innovation Task Force, and issues recommendations in the European Pharmacopoeia. International collaboration through the 3Rs Working Group ensures harmonised adoption of NAMs and the phasing out of obsolete tests.
Draft reflection papers on non-human primate testing and other regulatory requirements are open for public consultation until January 2026.
Read more here
